Swedbank
GMED icon

Swedbank’s Globus Medical GMED Stock Holding History

Swedbank’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1M Sell
520,363
-42,040
-7% -$3.57M 0.04% 269
2026
Q1 		$48.5M Buy
562,403
+32,000
+6% +$2.87M 0.05% 228
2025
Q4 		$46.3M Sell
530,403
-148,672
-22% -$11.3M 0.04% 234
2025
Q3 		$38.9M Buy
679,075
+50,000
+8% +$2.88M 0.04% 259
2025
Q2 		$37.1M Buy
629,075
+130,586
+26% +$8.44M 0.04% 257
2025
Q1 		$36.5M Buy
498,489
+23,000
+5% +$1.9M 0.05% 242
2024
Q4 		$39.3M Buy
475,489
+75,489
+19% +$5.95M 0.05% 234
2024
Q3 		$28.6M Buy
400,000
+25,000
+7% +$1.76M 0.04% 279
2024
Q2 		$25.7M Buy
375,000
+50,000
+15% +$2.99M 0.03% 280
2024
Q1 		$17.4M Buy
+325,000
New +$17.5M 0.15% 217
2022
Q2 		– Sell
-255,000
Closed -$18.8M – 755
2022
Q1 		$18.8M Hold
255,000
– – 0.03% 344
2021
Q4 		$18.5M Hold
255,000
– – 0.03% 366
2021
Q3 		$19.5M Hold
255,000
– – 0.04% 347
2021
Q2 		$19.8M Hold
255,000
– – 0.04% 352
2021
Q1 		$15.7M Buy
+255,000
New +$16.1M 0.03% 374

Other funds holding GMED

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TB
Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return

Swedbank's GMED Position: Q2 2026 in Review

Swedbank reduced its Globus Medical (GMED) stake by 7.5% in Q2 2026, selling an estimated $3.57M and leaving 520,363 shares worth $41.1M. The position accounts for 0.04% of the portfolio, ranked #269.

Swedbank first reported a position in GMED in Q1 2021 and has held it in 15 quarters since. The position peaked at $48.5M in Q1 2026. 199 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Swedbank held 520,363 shares of Globus Medical worth $41.1M as of Q2 2026.
  • Swedbank sold 42,040 Globus Medical shares in Q2 2026, an estimated $3.57M.
  • Globus Medical made up 0.04% of Swedbank's portfolio in Q2 2026, its #269 holding.
  • Swedbank first reported a position in Globus Medical in Q1 2021 and has held it in 15 quarters since.
  • Swedbank's Globus Medical position peaked at $48.5M in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.